Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 2nd generation of miRCURY LNA™ microRNA Inhibitor libraries for genome-wide screening of microRNA function in human and mouse. Several libraries have already been shipped to the first customers. The new human microRNA inhibitor library targets […]
NEWARK, Del.–SDIX™ (NASDAQ: SDIX), a leading supplier of rapid detection solutions to the $1 billion food pathogen testing market, today announced that its RapidChek® SELECT™ Salmonella Enteritidis (SE) test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard […]
Combination Enhances Illumina’s Sample Preparation and Enzyme Portfolio SAN DIEGO – Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Epicentre Biotechnologies, a leading provider of nucleic acid sample preparation reagents and specialty enzymes used in sequencing and microarray applications. A key component of the acquisition is direct access to Epicentre’s proprietary Nextera(TM) technology for […]
MADISON, Wis. – EraGen Biosciences Inc. today announced the appointment of industry veteran Gregory D. Rodgers as vice president of manufacturing. Mr. Rodgers brings to EraGen more than 30 years of manufacturing and operating experience, including two decades of in vitro diagnostic device manufacturing experience. He has a unique breadth and depth of experience in […]
GILBERTSVILLE, Pa.–Rockland Immunochemicals Inc., (www.rockland-inc.com) a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies “Biosimilars” for the Treatment of Cancer. […]
Biomarker Assay Services in Drug Development Rockville, MD – Expression Pathology Inc. announced an agreement with Roche (SIX:RO, ROG; OTCQX:RHHBY) wherein Expression Pathology will provide its Liquid Tissue®- SRM Technology to accelerate identification of cancer molecular markers for developing more effective treatments. Under the terms of the agreement, Expression Pathology will support Roche oncology drug […]
Highly Efficient, Reproducible Non-Cytotoxic Transfection Reagent GenePORTER® Gold from AMSBIO is a new highly efficient and reproducible lipid-based reagent for effective transfection of a wide variety of cell lines. Molecular target delivery faces many barriers, from crossing the cell type-specific extracellular membrane, to cytoplasmic degradation and translocation across the nuclear membrane. To be effective, the […]
Strasbourg, France – Polyplus-transfection SA, which specializes in the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, announces the completion of a funding round in which it raised EUR 2.5 million. This new round brings in new shareholders in Polyplus-transfection, AIRFI (Alsace Inter Regio Fonds d’Investissement) and Sudinnova, which […]
Cosmo Bio Co., Ltd. is a distributor of high quality research reagents and instruments throughout Japan. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for […]
Jena – Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) has increased its stake in subsidiary AJ Innuscreen GmbH to 100.0% and is now its sole owner. Thus, the Jena-based manufacturer of analytical instrumentation technology is continuing its strategic course of stepping up its life cycle business. “With its high level of investment in the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
